Skip to main content

Peer Review reports

From: Treatment of Middle East respiratory syndrome with a combination of lopinavir/ritonavir and interferon-β1b (MIRACLE trial): statistical analysis plan for a recursive two-stage group sequential randomized controlled trial

Original Submission
9 Dec 2018 Submitted Original manuscript
24 Jan 2019 Reviewed Reviewer Report - LAURA RICHERT
1 Jul 2019 Author responded Author comments - Yaseen Arabi
Resubmission - Version 2
1 Jul 2019 Submitted Manuscript version 2
9 Jul 2019 Reviewed Reviewer Report - LAURA RICHERT
7 Oct 2019 Author responded Author comments - Yaseen Arabi
Resubmission - Version 3
7 Oct 2019 Submitted Manuscript version 3
13 Oct 2019 Reviewed Reviewer Report - LAURA RICHERT
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
24 Oct 2019 Editorially accepted
3 Jan 2020 Article published 10.1186/s13063-019-3846-x

You can find further information about peer review here.

Back to article page

Trials

ISSN: 1745-6215